Journal ArticleTomography · September 26, 2023
CT pulmonary angiography is commonly used in diagnosing chronic thromboembolic pulmonary hypertension (CTEPH). This work was conducted to determine if cardiac chamber size on CTPA may also be useful for predicting the outcome of CTEPH treatment. A retrospe ...
Full textLink to itemCite
Journal ArticleJ Heart Lung Transplant · August 2023
BACKGROUND: Chronic thromboembolic pulmonary hypertension (CTEPH) is primarily managed by pulmonary thromboendarterectomy (PTE). As advanced surgical techniques permit resection at the segmental and subsegmental level, PTE can now be curative for CTEPH mos ...
Full textLink to itemCite
Journal ArticleJACC: Advances · May 1, 2023
Background: Balloon pulmonary angioplasty (BPA) is rapidly evolving therapeutic option for patients with nonsurgical chronic thromboembolic pulmonary hypertension (CTEPH). There are few U.S. studies that have reported on the outcomes of this novel therapeu ...
Full textCite
Journal ArticleTomography · November 17, 2022
Atrial size is a predictor of cardiovascular mortality. Non-ECG-gated computed tomography pulmonary angiography (CTPA) is a common test for cardiopulmonary evaluation but normative values for biatrial volumes are lacking. We derived normal CT biatrial volu ...
Full textLink to itemCite
Journal ArticleJournal of the Society for Cardiovascular Angiography and Interventions · November 1, 2022
Balloon pulmonary angioplasty (BPA) is an evolving treatment modality for patients with chronic thromboembolic pulmonary hypertension (CTEPH) who are not candidates for pulmonary endarterectomy. Although several imaging modalities currently exist for evalu ...
Full textCite
Journal ArticleLancet Haematol · September 2022
The International Consortium for Health Outcomes Measurement assembled an international working group of venous thromboembolism experts and patient representatives to develop a standardised minimum set of outcomes and outcome measurements for integration i ...
Full textLink to itemCite
Journal ArticlePulmonary Circulation · January 1, 2022
Inflammatory pseudotumor (IPT), also known as plasma cell granuloma, is a rare lesion of unknown etiology that occurs in many organs, especially in the lung. Here we report five cases of IPT arising in pulmonary artery mimicking chronic thromboembolic dise ...
Full textCite
ConferenceChest · November 2021
BACKGROUND: The United States Chronic Thromboembolic Pulmonary Hypertension Registry (US-CTEPH-R) was designed to characterize the demographic characteristics, evaluation, clinical course, and outcomes of surgical and nonsurgical therapies for patients wit ...
Full textLink to itemCite
Journal ArticleJ Heart Lung Transplant · November 2021
ISHLT members have recognized the importance of a consensus statement on the evaluation and management of patients with chronic thromboembolic pulmonary hypertension. The creation of this document required multiple steps, including the engagement of the IS ...
Full textLink to itemCite
Journal ArticleJACC Cardiovasc Interv · September 13, 2021
OBJECTIVES: The aim of this study was to investigate the incidence of May-Thurner anatomy (MTA) in patients with chronic thromboembolic pulmonary hypertension (CTEPH) and identify its predictors. BACKGROUND: MTA is an anatomical variant characterized by co ...
Full textLink to itemCite
Journal ArticleJMIR Research Protocols · May 1, 2021
Background: Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare sequela of acute pulmonary embolism that is treatable when recognized. Awareness of this disease has increased with recent advancements in therapeutic options, but delays in diagno ...
Full textCite
Journal ArticleAnn Thorac Surg · May 2021
BACKGROUND: At the University of California, San Diego, routine coronary angiography has generally been performed in men 40 years of age and older and women 45 years of age and older before pulmonary thromboendarterectomy for chronic thromboembolic pulmona ...
Full textLink to itemCite
Chapter · April 15, 2021
Chronic thromboembolic pulmonary hypertension (CTEPH) is a unique form of pulmonary vascular disease. This chapter will provide an overview of current insights into the prevalence and pathophysiology of this disease, review the diagnostic approach to patie ...
Cite
Journal ArticleJ Am Heart Assoc · November 3, 2020
Background Hypodense filling defects within the pulmonary veins on computed tomography described as pulmonary vein sign (PVS) have been noted in acute pulmonary embolism and shown to be associated with poor prognosis. We evaluated venous flow abnormalities ...
Full textLink to itemCite
Journal ArticleAnn Thorac Surg · September 2020
Perioperative anticoagulation management for patients with heparin-induced thrombocytopenia requiring cardiopulmonary bypass and deep hypothermic circulatory arrest presents a clinical challenge. Alternative anticoagulants have been used but can cause sign ...
Full textLink to itemCite
Journal ArticleCardiol Clin · May 2020
The treatment of chronic thromboembolic pulmonary hypertension has expanded considerably. The ability to endarterectomize chronic thromboembolic material, the availability of pulmonary hypertension medical therapy to treat inoperable chronic thromboembolic ...
Full textLink to itemCite
Journal ArticleTomography · September 26, 2023
CT pulmonary angiography is commonly used in diagnosing chronic thromboembolic pulmonary hypertension (CTEPH). This work was conducted to determine if cardiac chamber size on CTPA may also be useful for predicting the outcome of CTEPH treatment. A retrospe ...
Full textLink to itemCite
Journal ArticleJ Heart Lung Transplant · August 2023
BACKGROUND: Chronic thromboembolic pulmonary hypertension (CTEPH) is primarily managed by pulmonary thromboendarterectomy (PTE). As advanced surgical techniques permit resection at the segmental and subsegmental level, PTE can now be curative for CTEPH mos ...
Full textLink to itemCite
Journal ArticleJACC: Advances · May 1, 2023
Background: Balloon pulmonary angioplasty (BPA) is rapidly evolving therapeutic option for patients with nonsurgical chronic thromboembolic pulmonary hypertension (CTEPH). There are few U.S. studies that have reported on the outcomes of this novel therapeu ...
Full textCite
Journal ArticleTomography · November 17, 2022
Atrial size is a predictor of cardiovascular mortality. Non-ECG-gated computed tomography pulmonary angiography (CTPA) is a common test for cardiopulmonary evaluation but normative values for biatrial volumes are lacking. We derived normal CT biatrial volu ...
Full textLink to itemCite
Journal ArticleJournal of the Society for Cardiovascular Angiography and Interventions · November 1, 2022
Balloon pulmonary angioplasty (BPA) is an evolving treatment modality for patients with chronic thromboembolic pulmonary hypertension (CTEPH) who are not candidates for pulmonary endarterectomy. Although several imaging modalities currently exist for evalu ...
Full textCite
Journal ArticleLancet Haematol · September 2022
The International Consortium for Health Outcomes Measurement assembled an international working group of venous thromboembolism experts and patient representatives to develop a standardised minimum set of outcomes and outcome measurements for integration i ...
Full textLink to itemCite
Journal ArticlePulmonary Circulation · January 1, 2022
Inflammatory pseudotumor (IPT), also known as plasma cell granuloma, is a rare lesion of unknown etiology that occurs in many organs, especially in the lung. Here we report five cases of IPT arising in pulmonary artery mimicking chronic thromboembolic dise ...
Full textCite
ConferenceChest · November 2021
BACKGROUND: The United States Chronic Thromboembolic Pulmonary Hypertension Registry (US-CTEPH-R) was designed to characterize the demographic characteristics, evaluation, clinical course, and outcomes of surgical and nonsurgical therapies for patients wit ...
Full textLink to itemCite
Journal ArticleJ Heart Lung Transplant · November 2021
ISHLT members have recognized the importance of a consensus statement on the evaluation and management of patients with chronic thromboembolic pulmonary hypertension. The creation of this document required multiple steps, including the engagement of the IS ...
Full textLink to itemCite
Journal ArticleJACC Cardiovasc Interv · September 13, 2021
OBJECTIVES: The aim of this study was to investigate the incidence of May-Thurner anatomy (MTA) in patients with chronic thromboembolic pulmonary hypertension (CTEPH) and identify its predictors. BACKGROUND: MTA is an anatomical variant characterized by co ...
Full textLink to itemCite
Journal ArticleJMIR Research Protocols · May 1, 2021
Background: Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare sequela of acute pulmonary embolism that is treatable when recognized. Awareness of this disease has increased with recent advancements in therapeutic options, but delays in diagno ...
Full textCite
Journal ArticleAnn Thorac Surg · May 2021
BACKGROUND: At the University of California, San Diego, routine coronary angiography has generally been performed in men 40 years of age and older and women 45 years of age and older before pulmonary thromboendarterectomy for chronic thromboembolic pulmona ...
Full textLink to itemCite
Chapter · April 15, 2021
Chronic thromboembolic pulmonary hypertension (CTEPH) is a unique form of pulmonary vascular disease. This chapter will provide an overview of current insights into the prevalence and pathophysiology of this disease, review the diagnostic approach to patie ...
Cite
Journal ArticleJ Am Heart Assoc · November 3, 2020
Background Hypodense filling defects within the pulmonary veins on computed tomography described as pulmonary vein sign (PVS) have been noted in acute pulmonary embolism and shown to be associated with poor prognosis. We evaluated venous flow abnormalities ...
Full textLink to itemCite
Journal ArticleAnn Thorac Surg · September 2020
Perioperative anticoagulation management for patients with heparin-induced thrombocytopenia requiring cardiopulmonary bypass and deep hypothermic circulatory arrest presents a clinical challenge. Alternative anticoagulants have been used but can cause sign ...
Full textLink to itemCite
Journal ArticleCardiol Clin · May 2020
The treatment of chronic thromboembolic pulmonary hypertension has expanded considerably. The ability to endarterectomize chronic thromboembolic material, the availability of pulmonary hypertension medical therapy to treat inoperable chronic thromboembolic ...
Full textLink to itemCite
Journal ArticleCrit Care Med · December 2019
OBJECTIVES: To assess the efficacy of ramelteon in preventing delirium, an acute neuropsychiatric condition associated with increased morbidity and mortality, in the perioperative, ICU setting. DESIGN: Parallel-arm, randomized, double-blinded, placebo-cont ...
Full textLink to itemCite
Journal ArticleJ Card Surg · May 2019
BACKGROUND AND OBJECTIVES: Atrial arrhythmias (AAs) are common after cardiac surgeries including pulmonary thromboendarterectomy (PTE). This study was done to identify patients at highest risk of developing post-PTE AA and their length of stay (LOS). METHO ...
Full textLink to itemCite
Journal ArticleEur Respir J · March 2019
Chronic thromboembolic pulmonary hypertension (CTEPH) is an important consequence of pulmonary embolism that is associated with abnormalities in haemostasis. We investigated the ADAMTS13-von Willebrand factor (VWF) axis in CTEPH, including its relationship ...
Full textLink to itemCite
Journal ArticlePulmonary Circulation · January 1, 2019
Uterine fibroids have been described as an associate to acute venous thromboembolism (VTE), with case reports showing an association between large uterine fibroids, acute deep venous thrombosis (DVT), and acute pulmonary embolism (PE). However, there is li ...
Full textCite
Journal ArticlePulmonary Circulation · January 1, 2019
This study aimed to validate an algorithm developed to identify chronic thromboembolic pulmonary hypertension (CTEPH) among patients with a history of pulmonary embolism. Validation was halted because too few patients had gold-standard evidence of CTEPH in ...
Full textCite
Journal ArticleJACC Clin Electrophysiol · November 2018
OBJECTIVES: This study aimed to identify the prevalence of cardiac implantable electronic devices (CIEDs) in patients with chronic thromboembolic pulmonary hypertension (CTEPH) and to describe the associated disease burden. BACKGROUND: CTEPH is a debilitat ...
Full textLink to itemCite
Journal ArticleClin Chest Med · September 2018
Chronic thromboembolic pulmonary hypertension (CTEPH) is a progressive pulmonary vascular disease with significant morbidity. It is a result of an alternate natural history in which there is limited resolution of thromboemboli with pulmonary artery obstruc ...
Full textLink to itemCite
Journal ArticleJ Am Coll Cardiol · May 29, 2018
Chronic thromboembolic pulmonary hypertension (CTEPH), a rare consequence of an acute pulmonary embolism, is a disease that is underdiagnosed, and surgical pulmonary thromboendarterectomy (PTE) remains the preferred therapy. However, determination of opera ...
Full textLink to itemCite
Journal ArticleStructural Heart · July 4, 2017
Background: Left ventricular dyssynchrony has been studied extensively, but this is not the case with right ventricular (RV) dyssynchrony. Our aim was to investigate RV dyssynchrony through 2D speckle strain imaging in patients with chronic thromboembolic ...
Full textCite
Journal ArticleEchocardiography · December 2016
BACKGROUND: Right ventricular function is impaired in chronic thromboembolic pulmonary hypertension (CTEPH). Tricuspid annular plane systolic excursion (TAPSE) and right ventricular fractional area change (RVFAC) have been shown to help assess right ventri ...
Full textLink to itemCite
ConferenceAnn Am Thorac Soc · July 2016
Pulmonary hypertension is defined by a mean pulmonary artery pressure greater than 25 mm Hg. Chronic thromboembolic pulmonary hypertension (CTEPH) is defined as pulmonary hypertension in the presence of an organized thrombus within the pulmonary vascular b ...
Full textLink to itemCite
Journal ArticleAnn Am Thorac Soc · July 2016
Chronic thromboembolic pulmonary hypertension is a progressive and life-threatening condition that is believed to be related to inadequate dissolution of acute pulmonary thromboemboli, followed by fibrotic organization. Without appropriate treatment, progr ...
Full textLink to itemCite
Journal ArticleHeart Fail Rev · May 2016
Pulmonary hypertension due to chronic thromboembolic disease is potentially curable with pulmonary thromboendarterectomy surgery. As a result, it is important for clinicians to recognize and appropriately diagnose this form of pulmonary hypertension. Advan ...
Full textLink to itemCite
Journal ArticleAm J Cardiol · March 15, 2016
Patients with chronic thromboembolic pulmonary hypertension (CTEPH) often have substantial right ventricular dysfunction. The resulting low cardiac index might predispose to sleep disordered breathing (SDB) by increasing ventilatory instability. The preval ...
Full textLink to itemCite
Journal ArticleMethodist Debakey Cardiovasc J · 2016
Chronic thromboembolic pulmonary hypertension (CTEPH) is a potentially curable disease when treated with pulmonary thromboendarterectomy (PTE). However, even at experienced surgical centers, nearly one-third of patients with CTEPH will be deemed inoperable ...
Full textLink to itemCite
Journal ArticleAnn Am Thorac Soc · October 2015
RATIONALE: Reperfusion lung injury is a postoperative complication of pulmonary thromboendarterectomy that can significantly affect morbidity and mortality. Studies in other postoperative patient populations have demonstrated a reduction in acute lung inju ...
Full textLink to itemCite
Journal ArticleEchocardiography · July 2015
BACKGROUND: Right ventricular (RV) function is significantly impaired in patients with chronic thromboembolic pulmonary hypertension (CTEPH). Two-dimensional speckle tracking RV strain and strain rate are novel methods to assess regional RV systolic functi ...
Full textLink to itemCite
Journal ArticlePulmonary Circulation · June 1, 2015
This study sought to determine the prevalence of coronary artery-pulmonary artery collaterals in patients with chronic thromboembolic pulmonary hypertension (CTEPH) and to correlate their presence with the degree of clot burden. CTEPH is a treatable cause ...
Full textCite
Chapter · January 1, 2015
Over the past quarter century, the recognition, evaluation, and management of patients with chronic thromboembolic pulmonary hypertension (CTEPH) have experienced considerable forward strides. This has been accompanied by a better understanding of the risk ...
Full textCite
Journal ArticleAnn Thorac Surg · November 2014
BACKGROUND: Obesity is a common comorbidity of patients with chronic thromboembolic pulmonary hypertension referred for pulmonary thromboendarterectomy, yet the effect of obesity on pulmonary thromboendarterectomy outcomes has not been well described. METH ...
Full textLink to itemCite
Journal ArticleCardiovasc Ultrasound · August 11, 2014
BACKGROUND: Impaired left ventricular diastolic filling is common in chronic thromboembolic pulmonary hypertension (CTEPH), and recent studies support left ventricular underfilling as a cause. To investigate this further, we assessed left atrial volume ind ...
Full textLink to itemCite
Journal ArticleEchocardiography · 2014
UNLABELLED: The ratio of tricuspid regurgitation velocity divided by the velocity-time integral of right ventricular outflow tract pulsed-wave Doppler tracing (TRV/VTI(RVOT) ) has been used to estimate pulmonary vascular resistance (PVR). However, this met ...
Full textLink to itemCite
Journal ArticleClin Chest Med · December 2013
Chronic thromboembolic pulmonary hypertension (CTEPH) is a disease with high mortality and few treatment options. This article reviews the epidemiology of CTEPH and identifies risk factors for its development. The pathobiology and the progression from thro ...
Full textLink to itemCite
Journal ArticleEchocardiography · November 2013
BACKGROUND: Although studies have found diminished aortic root motion in left ventricular systolic dysfunction, few data exist on aortic root excursion in isolated right ventricular dysfunction due to chronic thromboembolic pulmonary hypertension (CTEPH). ...
Full textLink to itemCite
Journal ArticleAnn Thorac Surg · July 2012
BACKGROUND: Chronic thromboembolic pulmonary hypertension (CTEPH) is a known sequela of acute pulmonary embolic disease and yet remains underdiagnosed. Although nonsurgical options for patients with CTEPH have become increasingly available, including pulmo ...
Full textLink to itemCite
Journal ArticlePulmonary Circulation · April 1, 2012
Pulmonary hypertension as a result of chronic thromboembolic disease (CTEPH) is potentially curable with pulmonary endarterectomy surgery. Consequently, correctly diagnosing patients with this type of pulmonary hypertension and evaluating these patients wi ...
Full textCite
Journal ArticleChest · January 1, 2012
Background: We sought to determine the efficacy and safety of perioperative treatment with methylprednisolone on the development of lung injury after pulmonary thromboendarterectomy. Methods: This was a randomized, prospective, double-blind, placebo-contro ...
Full textCite
Journal ArticleAm J Respir Crit Care Med · June 15, 2011
Over the past 4 decades, chronic thromboembolic pulmonary hypertension has evolved from an autopsy curiosity to a potentially correctable form of pulmonary hypertension. Advances in surgical techniques along with the introduction of pulmonary hypertension ...
Full textLink to itemCite
Journal ArticleJ Thorac Cardiovasc Surg · March 2011
OBJECTIVE: Chronic thromboembolic pulmonary hypertension is a rare form of pulmonary hypertension that can lead to progressive right heart failure and death. Pulmonary thromboendarterectomy surgery is the treatment of choice resulting in significant improv ...
Full textLink to itemCite
Journal ArticleClin Chest Med · December 2010
Chronic thromboembolic pulmonary hypertension is one of the few forms of pulmonary hypertension that is surgically curable. It is likely underdiagnosed and must be considered in every patient presenting with pulmonary hypertension to avoid missing the oppo ...
Full textLink to itemCite
Journal ArticleCardiovasc Ultrasound · September 27, 2010
BACKGROUND: Echocardiographic evaluation of left ventricular (LV) strain and strain rate (SR) by 2D speckle tracking may be useful tools to assess chronic thromboembolic pulmonary hypertension (CTEPH) severity as well as response to successful pulmonary th ...
Full textLink to itemCite
Journal ArticleCurrent Treatment Options in Cardiovascular Medicine · April 1, 2010
The pulmonary hypertension (PH) and right heart dysfunction that results from chronic thromboembolic involvement of the pulmonary vascular bed is potentially curable with surgical endarterectomy. Over the past several decades, growing clinical experience h ...
Full textCite
Journal ArticleAm J Physiol Lung Cell Mol Physiol · October 2009
Pulmonary vascular remodeling occurs in patients with chronic thromboembolic pulmonary hypertension (CTEPH). One factor contributing to this vascular wall thickening is the proliferation of pulmonary artery smooth muscle cells (PASMC). Store-operated Ca(2+ ...
Full textLink to itemCite
Journal ArticleCirculation · September 29, 2009
BACKGROUND: The currently recommended treatment for chronic thromboembolic pulmonary hypertension is pulmonary thromboendarterectomy (PTE). No convincing evidence for the use of pulmonary hypertensive medical therapy (PHT) exists in operable candidates. We ...
Full textLink to itemCite
Journal ArticleSemin Respir Crit Care Med · August 2009
The last 4 decades have witnessed dramatic changes in the treatment of patients with pulmonary hypertension. And with the advances in cardiothoracic surgical techniques, selected patients with chronic thromboembolic pulmonary hypertension (CTEPH) are affor ...
Full textLink to itemCite
Journal ArticleAm J Physiol Lung Cell Mol Physiol · June 2009
Chronic thromboembolic pulmonary hypertension (CTEPH) is characterized by a fibrotic thrombus persisting and obliterating the lumen of pulmonary arteries; its pathogenesis remains poorly defined. This study investigates a potential contribution for progeni ...
Full textLink to itemCite
Journal ArticleJACC Cardiovasc Imaging · February 2009
OBJECTIVES: We evaluated the utility of tissue Doppler-derived right ventricular (RV) Tei (or myocardial performance) index in patients with chronic thromboembolic pulmonary hypertension (CTEPH) before and after pulmonary thromboendarterectomy (PTE) and as ...
Full textLink to itemCite
Journal ArticleJAMA · August 20, 2008
CONTEXT: Ventilator-associated pneumonia (VAP) causes substantial morbidity. A silver-coated endotracheal tube has been designed to reduce VAP incidence by preventing bacterial colonization and biofilm formation. OBJECTIVE: To determine whether a silver-co ...
Full textLink to itemCite
Journal ArticleJ Am Soc Echocardiogr · October 2007
BACKGROUND: Pulmonary artery pressure (PAP) and pulmonary vascular resistance (PVR) are important hemodynamic parameters in patients with advanced cardiopulmonary disease. We undertook this study to determine whether Doppler tissue imaging of the tricuspid ...
Full textLink to itemCite
Journal ArticleJ Am Coll Cardiol · March 27, 2007
OBJECTIVES: The purpose of this study was to investigate the cause of abnormal left ventricular (LV) Doppler diastolic filling characteristics in chronic thromboembolic pulmonary hypertension (CTEPH). BACKGROUND: In CTEPH, LV diastolic function often appea ...
Full textLink to itemCite
Journal ArticleClin Chest Med · March 2007
The description of organized thrombus in major pulmonary arteries can be found in autopsy reports dating back to the late nineteenth and early twentieth centuries. Not until the 1950s was the antemortem diagnosis and clinical syndrome of chronic thrombotic ...
Full textLink to itemCite
Journal ArticleJ Cardiothorac Vasc Anesth · February 2007
OBJECTIVE: The purpose of this study was to evaluate the accuracy and precision of a novel algorithm that evaluates cardiac output by using arterial pressure waveform characteristics. DESIGN: Prospective, observational study comparing the cardiac output va ...
Full textLink to itemCite
Journal ArticleAnn Thorac Surg · December 2006
BACKGROUND: Pulmonary endarterectomy is the accepted therapy for thromboembolic pulmonary hypertension. A recognized complication of this surgery is the postoperative development of reperfusion edema, a potentially fatal cause of respiratory failure. Becau ...
Full textLink to itemCite
Journal ArticleAm J Respir Crit Care Med · June 1, 2006
RATIONALE: Although acute pulmonary embolism is epidemiologically associated with chronic thromboembolic pulmonary hypertension, the factors responsible for resistance to thrombolysis and a shift toward vascular remodeling within the pulmonary arteries of ...
Full textLink to itemCite
Journal ArticleSemin Thorac Cardiovasc Surg · 2006
Chronic thromboembolic obstruction of the pulmonary vascular bed has been increasingly recognized as a treatable form of pulmonary hypertension, with surgery referred to as a pulmonary endarterectomy. Careful evaluation of patients with pulmonary hypertens ...
Full textLink to itemCite
Journal ArticleSemin Thorac Cardiovasc Surg · 2006
Recent efforts have seen major advances in elucidating the mechanisms underlying pulmonary arterial hypertension. However, chronic thromboembolic pulmonary hypertension (CTEPH) often has been excluded from these studies. Consequently, whereas the clinical, ...
Full textLink to itemCite
Journal ArticleSemin Cardiothorac Vasc Anesth · September 2005
Chronic thromboembolic pulmonary hypertension results from incomplete resolution of a pulmonary embolus or from recurrent pulmonary emboli. Its incidence is underappreciated, and it is currently an undertreated phenomenon. Pulmonary thromboendarterectomy i ...
Full textLink to itemCite
Journal ArticleAnesth Analg · September 2004
Pulmonary thromboendarterectomy, the most common surgical treatment of chronic thromboembolic pulmonary hypertension, is being performed with increasing frequency throughout the world. Massive pulmonary hemorrhage is a potentially fatal complication of thi ...
Full textLink to itemCite
Journal ArticleCardiol Clin · August 2004
During the past 2 decades, there has been a steady rise in the number of patients with chronic thromboembolic pulmonary hypertension (CTEPH) undergoing surgery and in the number of programs worldwide dedicated to the diagnosis and management of this patien ...
Full textLink to itemCite
Journal ArticleJ Cardiothorac Vasc Anesth · April 2004
OBJECTIVES: To determine the femoral-to-radial arterial pressure gradient, as well as the factors associated with them, in patients receiving cardiopulmonary bypass (CPB) with profound hypothermia and circulatory arrest. DESIGN: Retrospective automated hem ...
Full textLink to itemCite
Journal ArticleEur Respir J · April 2004
Pathophysiological findings in chronic thromboembolic pulmonary hypertension (CTEPH) have suggested that a secondary small vessel arteriopathy may contribute to the haemodynamic impairment observed in these patients. It was hypothesised that this element o ...
Full textLink to itemCite
Journal ArticleAnn Thorac Surg · November 2003
BACKGROUND: The incidence of pulmonary hypertension resulting from chronic thrombotic occlusion of the pulmonary arteries is significantly underestimated. Although medical therapy for the condition is supportive only, surgical therapy is curative. Our pulm ...
Full textLink to itemCite
Journal ArticleSeminars in Respiratory and Critical Care Medicine · June 1, 2003
Over the past 4 decades, chronic thromboembolic pulmonary hypertension has evolved from an autopsy curiosity to a potentially correctable form of pulmonary hypertension. Approximately 2500 thromboendarterectomy procedures have now been performed worldwide ...
Full textCite
Journal ArticleCatheter Cardiovasc Interv · February 2003
Balloon angioplasty and stent placement for pulmonary arterial stenoses in children are well-established therapies. In contrast, management of isolated peripheral pulmonary arterial stenoses in adults remains relatively unexplored. Four women (ages 18-63 y ...
Full textLink to itemCite
Journal ArticleAnesth Analg · August 2002
Sudden loss of thermodilution or temperature-monitoring capabilities of an indwelling pulmonary artery catheter may indicate significant damage to the catheter, possibly leading to electrical hazard and infection risk. Blood appearing at the electrical con ...
Full textLink to itemCite
Journal ArticleJ Am Coll Cardiol · July 17, 2002
OBJECTIVES: This study was designed to determine a quantitative relationship between right ventricular (RV) pressure overload and left ventricular (LV) diastolic filling characteristics in patients with chronic thromboembolic pulmonary hypertension (CTEPH) ...
Full textLink to itemCite
Journal ArticleRegul Pept · October 15, 2001
Parathyroid hormone-related protein (PTHrP) is an autocrine growth and differentiation factor for alveolar type II epithelial cells. Type II cells secrete pulmonary surfactant and are pluripotent cells with a role in alveolar epithelial repair after lung i ...
Full textLink to itemCite
Journal ArticleClin Chest Med · September 2001
Remarkable advances have occurred over the past 2 decades in the diagnostic approach, surgical management, and postoperative care of patients afflicted with chronic thromboembolic pulmonary hypertension. Despite these advances, a great deal needs to be ach ...
Full textLink to itemCite
Journal ArticleAnn Thorac Surg · July 2001
BACKGROUND: Patients with pulmonary hypertension due to chronic thromboembolic disease benefit from pulmonary thromboendarterectomy. A subset of these patients present with concomitant coronary or valvular disease. METHODS: From July 1990 to July 2000, 90 ...
Full textLink to itemCite
Journal ArticleJ Vasc Interv Radiol · June 2001
A patient diagnosed with chronic thromboembolic disease experienced a fatal intraprocedural paradoxic embolism during inferior vena cava (IVC) filter insertion. The frequency of patent intra-atrial shunts in patients with chronic thromboembolic disease is ...
Full textLink to itemCite
Journal ArticleJ Am Soc Echocardiogr · January 2001
BACKGROUND: Although rarely seen in healthy patients, the coronary sinus (CS) is often visualized on echocardiography in patients with right-sided heart disease. However, the prevalence of this finding and its relation to right-sided heart structure and pr ...
Full textLink to itemCite
Journal ArticleAm J Respir Crit Care Med · November 2000
"High-probability" ventilation/perfusion (V/Q) lung scans generally indicate proximal pulmonary arterial occlusion by thromboemboli or, rarely, other processes such as tumors, fibrosing mediastinitis, or vasculitis. In this report we describe three patient ...
Full textLink to itemCite
Journal ArticleAm J Respir Crit Care Med · July 2000
Pulmonary thromboendartectomy (PTE) for chronic thromboembolic pulmonary hypertension may be complicated by reperfusion lung injury. This has previously been demonstrated to be neutrophil-mediated. We postulated that blocking selectin-mediated adhesion of ...
Full textLink to itemCite
Journal ArticleChest · May 2000
Klippel-Trenaunay syndrome (KTS) is a congenital disorder characterized by a triad of cutaneous vascular nevi, soft tissue or bony hypertrophy, and varicose veins or venous malformations involving one or more extremities. An incidence of venous thromboembo ...
Full textLink to itemCite
Journal ArticleAJR Am J Roentgenol · February 2000
OBJECTIVE: We sought to identify imaging features that help predict surgical success in patients undergoing thromboendarterectomy. MATERIALS AND METHODS: Thirty-nine consecutive patients who underwent pulmonary angiography and thromboendarterectomy during ...
Full textLink to itemCite
Journal ArticleSeminars in Respiratory and Critical Care Medicine · January 1, 2000
Under most circumstances, chronic thromboembolic pulmonary hypertension represents a correctable form of pulmonary hypertension. Approximately 1500 thromboendarterectomy procedures have now been performed worldwide. Mortality rates reported by established ...
Full textCite
Journal ArticleAnn Thorac Surg · November 1999
BACKGROUND: Recurrent symptomatic pulmonary hypertension is uncommon after primary pulmonary thromboendarterectomy (PTE). We reviewed our experience with patients undergoing repeat PTE to determine the risk factors for recurrent disease, and the selection ...
Full textLink to itemCite
Journal ArticleAm J Cardiol · September 15, 1999
Long waiting times for lung transplantation have limited the survival of patients with advanced pulmonary hypertension. Atrial septostomy has been used in this group of patients in an attempt to prolong survival. We evaluated the results of atrial septosto ...
Full textLink to itemCite
Journal ArticleAm J Respir Crit Care Med · August 1999
This study evaluated long-term outcome of pulmonary thromboendarterectomy (PTE) in patients with chronic thromboembolic pulmonary hypertension (CTEPH). Survival, functional status, quality of life, health care utilization, and relationships between these p ...
Full textLink to itemCite
Journal ArticleSemin Thorac Cardiovasc Surg · April 1999
Chronic thromboembolic pulmonary hypertension (CTEPH) can be a difficult diagnosis to establish, typically requiring a high index of suspicion on the part of the clinician when challenged by a patient reporting exertional dyspnea. The importance of this di ...
Full textLink to itemCite
Journal ArticleSemin Thorac Cardiovasc Surg · April 1999
Obstruction of major pulmonary vessels with organized thromboemboli is a rare sequelae of acute pulmonary embolic disease. Depending on the extent and duration of vascular occlusion, patients experiencing this unusual disorder may develop significant pulmo ...
Full textLink to itemCite
Journal ArticleSemin Thorac Cardiovasc Surg · April 1999
The postoperative course of the patient undergoing pulmonary thromboendarterectomy poses a unique series of challenges in terms of ventilatory care and hemodynamic management. Experience, cooperation, and interaction are necessary among the various discipl ...
Full textLink to itemCite
Journal ArticleSemin Thorac Cardiovasc Surg · April 1999
Pulmonary thromboendarterectomy (PTE) surgery is an effective treatment for the majority of patients with chronic thromboembolic pulmonary hypertension (CTEPH), with an acceptable mortality rate. The immediate outcome after PTE has repeatedly shown a drama ...
Full textLink to itemCite
Journal ArticleAm J Respir Crit Care Med · May 1998
Patients with sickle cell disease have been reported to have an increased risk of thromboembolism and pulmonary hypertension. Some of these patients may benefit from pulmonary thromboendarterectomy (PTE), a procedure that requires profound hypothermia, car ...
Full textLink to itemCite
Journal ArticleRadiology · September 1997
PURPOSE: To evaluate the accuracy of identification of central and segmental chronic thromboembolic disease on helical computed tomographic (CT) scans and on magnetic resonance (MR) images. MATERIALS AND METHODS: Radiologic findings in 55 patients suspecte ...
Full textLink to itemCite
Journal ArticleAm J Cardiol · September 1, 1996
Right ventricular free wall biopsy specimens in 40 patients undergoing surgery for relief of chronic thromboembolic pulmonary hypertension were normal in 5%, disclosed only myocyte hypertrophy in 80%, mild focal fibrosis in 12.5%, and myocarditis in 2.5%. ...
Full textLink to itemCite
Journal ArticleChest · August 1996
UNLABELLED: The finding of a restrictive pulmonary defect may divert clinicians from considering the diagnosis of chronic thromboembolic pulmonary hypertension because lung volumes are usually normal in this disorder. We have, however, encountered a signif ...
Full textLink to itemCite
Journal ArticleAm J Respir Crit Care Med · August 1996
The characteristics and postoperative outcomes of a unique group of eleven patients with total unilateral pulmonary artery (PA) thromboembolic occlusion were compared with those of some 400 patients who underwent bilateral thromboendarterectomies during th ...
Full textLink to itemCite
Journal ArticleAJR Am J Roentgenol · June 1996
OBJECTIVE: The aims of this study were to determine the reliability of the high-resolution CT (HRCT) appearance of the lung parenchyma in distinguishing patients with chronic pulmonary thromboembolism (CPTE) from those with other pulmonary diseases and to ...
Full textLink to itemCite
Journal ArticleChest · January 1, 1996
Background: Inhaled nitric oxide (NO) has been shown to be a selective pulmonary vasodilator in certain patients with primary pulmonary hypertension (PPH). Objectives: The purpose of this study was to design and test a system for delivery of NO to awaken, ...
Full textCite
Journal ArticleAcad Radiol · January 1996
RATIONALE AND OBJECTIVES: We evaluated the accuracy of contrast-enhanced magnetic resonance (MR) angiography in demonstrating the findings of chronic pulmonary thromboembolism (CPTE) compared with conventional pulmonary angiography. METHODS: We examined 18 ...
Full textLink to itemCite
Journal ArticleJournal of Investigative Medicine · January 1, 1996
The characteristics and post-operative outcomes of eleven patients with total unilateral (UNI)pulmonary artery (PA) thromboembolic occlusion were compared with those of some 600 patients who underwent bilateral (BI) thromboendarterectomies during the same ...
Cite
Journal ArticleAm J Med · October 1995
PURPOSE: An increased occurrence of thrombotic events has been described in patients exhibiting a lupus anticoagulant (LA). In patients with chronic, major vessel thromboembolic pulmonary hypertension, not only has there been a relatively high frequency of ...
Full textLink to itemCite
Journal ArticleCurr Opin Pulm Med · July 1995
An ever-expanding body of information has provided new insights into the pathophysiologic mechanisms contributing to pulmonary hypertensive disease. The pulmonary endothelial cell has been shown to have a central role in both the maintenance of normal vasc ...
Link to itemCite
Journal ArticleAm J Respir Crit Care Med · July 1995
Chronic obstruction of pulmonary arteries can be due to a variety of disease processes, including chronic thromboembolic disease, fibrosing mediastinitis, or neoplasia. Large vessel arteritis is another unusual cause of pulmonary artery obstruction and can ...
Full textLink to itemCite
Journal ArticleClin Chest Med · June 1995
Chronic, major-vessel thromboembolic disease represents a potentially correctable form of pulmonary hypertension. A thorough understanding of the unique problems associated with each aspect of care in these patients is essential to ensure a minimal periope ...
Link to itemCite
Journal ArticleArch Pathol Lab Med · March 1995
Intravascular bronchioloalveolar tumor, the pulmonary counterpart of epithelioid hemangioendothelioma, typically presents as bilateral pulmonary nodules in young women. We report a case of intravascular bronchioloalveolar tumor that clinically mimicked acu ...
Link to itemCite
Journal ArticleJ Psychosom Res · January 1995
Patients on mechanical ventilation are occasionally hard to wean because of fatigue and/or depression. It is difficult to diagnose depression in this population, and treatment with traditional antidepressants has too slow an onset to be useful. Two cases a ...
Full textLink to itemCite
Journal ArticleRadiology · May 1994
PURPOSE: To study the relationship of regional hypoperfusion and areas of decreased lung attenuation on computed tomographic (CT) scans of patients with chronic pulmonary thromboembolism. MATERIALS AND METHODS: Preoperative CT scans of five patients (four ...
Full textLink to itemCite
Journal ArticleChest · November 1993
Patients who undergo thromboendarterectomy for relief of chronic, major-vessel thromboembolic pulmonary hypertension (CT-E PH) offer a unique opportunity to evaluate potential resolution of hypertensive lesions in the small, nonelastic pulmonary arteries. ...
Full textLink to itemCite
Journal ArticleJ Thorac Cardiovasc Surg · July 1993
A program to alleviate chronic, major vessel thromboembolic pulmonary hypertension by pulmonary thromboendarterectomy was initiated at this institution in 1970. Multiple evolutionary changes in the diagnostic evaluation, surgical approach, and postoperativ ...
Link to itemCite
Journal ArticleEur Respir J · March 1992
Chronic, major vessel thromboembolic pulmonary hypertension (CTEPH), is an uncommon condition which, in the past, was an autopsy curiosity. Advances in diagnostic approaches, surgical techniques and postoperative management have transformed this disorder i ...
Link to itemCite
Journal ArticleRadiology · February 1992
The pulmonary angiograms of 250 patients evaluated for chronic thromboembolic pulmonary hypertension were reviewed. Pulmonary thromboendarterectomy was performed in each of these individuals, and the surgical findings were correlated with abnormal angiogra ...
Full textLink to itemCite
Journal ArticleCirculation · January 1991
To map global epicardial repolarization patterns and test the "SI" model of T wave generation, the patterns of epicardial activation and repolarization in patients with chronic pulmonary thromboembolism and right ventricular hypertrophy were studied by com ...
Full textLink to itemCite
ConferenceChest · December 1990
After pulmonary thromboendarterectomy, performed for relief of chronic thromboembolic pulmonary hypertension, perfusion lung scans have frequently disclosed new perfusion defects in segments served by undissected pulmonary arteries. Our hypotheses were tha ...
Full textLink to itemCite
ConferenceJ Thorac Cardiovasc Surg · April 1990
Pulmonary thromboendarterectomy is being performed with increasing frequency for incapacitating pulmonary hypertension caused by chronic large-vessel pulmonary embolism. However, patient-related risk factors and procedural complications associated with mor ...
Link to itemCite
Journal ArticleJournal of Extra-Corporeal Technology · January 1, 1990
One hundred ninety-five patients with the diagnosis of chronic pulmonary thromboembolic pulmonary hypertension have been operated on utilizing a standardized protocol involving profound hypothermia and circulatory arrest. A small subgroup, nine, were ident ...
Cite